The Senate Finance Committee today held the first in a planned series of bipartisan hearings on high prescription drug prices and potential policy and oversight solutions to lower costs for patients. Witness Kathy Sego described her family’s struggle to afford insulin for her son, which costs them $487 per vial with insurance. Mark Miller, vice president of health care for the Laura and John Arnold Foundation and former executive director of the Medicare Payment Advisory Commission, discussed policy options to address rising drug costs in Medicare and Medicaid. Douglas Holtz-Eakin, president of the American Action Forum, called for promoting competition and financial incentives to keep costs and prices down. Peter Bach, a physician who leads the Drug Pricing Lab at Memorial Sloan Kettering Cancer Center in New York, said most participants in the pharmaceutical supply chain benefit from rising spending and prices due to “inflationary distortions” in the system. Chairman Chuck Grassley, R-Iowa, and Ranking Member Ron Wyden, D-Ore., said they plan to bring drug company executives before the panel in the future.

The House Committee on Oversight and Reform also held a hearing today on the issue. Witnesses included representatives from AARP, the Program on Regulation, Therapeutics and Law at Harvard Medical School, and Johns Hopkins University’s Bloomberg School of Public Health.

The AHA, Federation of American Hospitals and American Society of Health-System Pharmacists earlier this month released a report that found continued rising drug prices, as well as shortages for many critical medications, are disrupting patient care and forcing hospitals to delay infrastructure and staffing investments and identify alternative therapies. To restrain out-of-control drug prices, the AHA has recommended several options including stopping brand-name manufacturers' anticompetitive actions by addressing ever-greening and pay-for-delay practices, speeding up generic drug approvals, and passing the CREATES Act.

Related News Articles

Headline
The AHA June 29 sent a letter to senators urging them to amend the budget reconciliation bill before its final passage in the Senate. The Senate version of the…
Chairperson's File
Public
Advocacy is a core part of the work of the AHA, protecting and sustaining what hospitals and health systems need to truly care for our communities. We often…
Perspective
In the next few days, Senate Republican leaders plan to unveil and vote on their updated reconciliation bill, which, as currently constructed, would have far-…
Headline
The AHA today commented to House and Senate appropriations committee leaders on funding for health care programs in the fiscal year 2026 appropriations bill.…
Headline
Coalition ad links decisions on Medicaid cuts by Congress to impacts on hospitalsA new television and digital advertisement launched today by the Coalition to…
Perspective
Public
As the Senate eyes a vote next week on its reconciliation bill, the next few days are crucial for reaching out to your senators and urging them to make changes…